- Regulatory Affairs
- Medical Information
- Strategic Development
- A to Z of Services
The success of regulatory approvals is highly dependent on the quality of the data submitted. Completing a comprehensive review of regulatory requirements, designing studies to ensure they provide the necessary supportive evidence and assessing all the relevant existing scientific data, are the essential stages required in order to develop a solid route to market. Assessing scientific data can help companies answer important questions relating to particular components of a product development programme. The assessment may focus on quality (CMC), non-clinical or clinical information. Regulatory authority scientific advice provides an invaluable opportunity to ask prospective questions before the studies have taken place to ascertain whether the design of the study meets local or regional expectations and whether it is likely to generate data suitable for the application. The significance of this opportunity should not be underestimated. Identifying and resolving any weaknesses and omissions in the data at an early stage in the project, will allow sufficient time to resolve the issues and help gain regulatory authority endorsement whilst at the same time prevent any resultant delay to the approval process.
How can we help?
Our experienced consultants will design product development programmes, write protocols and/or perform all the necessary due diligence and assessments of study data in order to help you avoid pitfalls during your product’s development. We will support you in the development of your regulatory strategy, provide advice on clinical and non-clinical consultancy, manage applications for clinical trial authorisations, undertake clinical report writing and GCP audits, ensure you attain the necessary quality standards for dossier submission and despatch, as well as complete technical assessments to apply CMC guidance where appropriate. With a bank of experts qualified to write and sign off the quality overall summary, and non-clinical and clinical overviews, we will present and critique your data constructively in regulatory submissions to facilitate assessments and promote the outcomes you are striving for.
For a more detailed discussion on how we can help you, contact us on +44 (0)1628 530554 or email us via our contact form.REQUEST MORE INFORMATION